Elaine D. Sun

2021

In 2021, Elaine D. Sun earned a total compensation of $2.2M as Senior Vice President Chief Financial Officer at Halozyme Therapeutics, a 36% decrease compared to previous year.

Compensation breakdown

Option Awards$495,009
Salary$494,000
Stock Awards$1,155,062
Other$14,271
Total$2,158,342

Sun received $1.2M in stock awards, accounting for 54% of the total pay in 2021.

Sun also received $495K in option awards, $494K in salary and $14.3K in other compensation.

Rankings

In 2021, Elaine D. Sun's compensation ranked 5,759th out of 12,415 executives tracked by ExecPay. In other words, Sun earned more than 53.6% of executives.

ClassificationRankingPercentile
All
5,759
out of 12,415
54th
Division
Manufacturing
2,443
out of 5,505
56th
Major group
Chemicals And Allied Products
1,058
out of 2,375
56th
Industry group
Drugs
945
out of 2,096
55th
Industry
Biological Products, Except Diagnostic Substances
231
out of 449
49th

Pay ratio

Elaine D. Sun's Pay$2,158,342
Median Employee's Pay$291,734
Pay Ratio

7

to 1

In 2021, the annual total compensation of Elaine D. Sun was $2,158,342.

The annual total compensation of the median employee at Halozyme Therapeutics was $291,734.

The ratio of Elaine D. Sun's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on March 25, 2022.

Sun's colleagues

We found three more compensation records of executives who worked with Elaine D. Sun at Halozyme Therapeutics in 2021.

2021

Helen Torley

Halozyme Therapeutics

Chief Executive Officer

2021

Masaru Matsuda

Halozyme Therapeutics

General Counsel

2021

Michael LaBarre

Halozyme Therapeutics

Senior Vice President, Chief Technical Officer

News

You may also like